Mediators of Inflammation / 2019 / Article / Fig 1

Research Article

Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways

Figure 1

IH treatment, surgery, and the IH vehicle had no adverse effects on the liver. (a) Serum ALT and AST and liver hydroxyproline in the four study groups were not significantly different. Data are expressed as . (b) H&E and Masson’s trichrome staining of liver tissue did not show obvious pathological changes in the four groups (original magnification, ×200; scale bar, 100 μm).

We are experiencing issues with article search and journal table of contents. We are working on a fix as to remediate it and apologise for the inconvenience.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.